Pharmacia & Upjohn consumer health sales down 17.8% to $153.2 mil. in first quarter.
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN CONSUMER HEALTH FIRST QUARTER SALES DOWN 17.8% to $153.2 mil. First quarter 1996 consumer health care sales were up due to "significant" prestocking of Rogaine hair regrowth treatment and Nicorette smoking cessation gum in preparation of their OTC launches in the second quarter last year, Pharmacia & Upjohn said April 29. P&U manufactures Nicorette and markets it abroad; the product is marketed by SmithKline Beecham in the U.S.